alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 98-2706

DONNA PUGH, Plaintiff - Appellant, versusAIG LIFE INSURANCE COMPANY; AMERICAN INTERNATIONAL LIFE INSURANCE COMPANY OF NEW YORK; AMERICAN HOME ASSURANCE COMPANY; NATIONAL FIRE INSURANCE COMPANY OF PITTSBURGH, PENNSYLVANIA, Defendants - Appellees.Appeal from the United States District Court for the Middle District of North Carolina, at Winston-Salem. James A. Beaty, Jr., District Judge. (CA-96-135-6) Submitted: April 30, 1999 Decided: May 26, 1999 Before ERVIN, HAMILTON, and MOTZ, Circuit Judges. Affirmed by unpublished per curiam opinion. Donna Pugh, Appellant Pro Se. Joseph W. Moss, Matthew L. Mason, MOSS & MASON, Greensboro, North Carolina, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Donna Pugh sued the AIG Life Insurance Company (AIG) seeking benefits under her employer’s Permanent Total Disability insurance benefits plan, which is governed by the Employee Retirement Income Security Act of 1974, as amended. Pugh appeals from the orders denying her motion for a jury trial, granting summary judgment to AIG, and dismissing her action. We have reviewed the record and the district court’s opinions and find no reversible error. Accordingly, we affirm on the reasoning of the district court. See Pugh v. AIG Life Ins. Co. , No. CA-96-135-6 (M.D.N.C. Sept. 11, 1998; Oct. 13 & 16, 1998). We dispense with oral argument becausethe facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
<PAGE>

                                                                   EXHIBIT 10.61

                           CARDIAC SCIENCE CORPORATION
                            3303 MONTE VILLA PARKWAY
                                BOTHELL, WA 98021
                                 (425) 402-2000

                                November 9, 2005

Dr. Ruediger Naumann-Etienne
c/o Cardiac Science Corporation
3303 Monte Villa Parkway
Bothell, WA 98021

      RE: TERMINATION OF EMPLOYMENT AGREEMENT; SERVICES AGREEMENT

Dear Rudi:

      The purpose of this letter is to set forth the terms of our agreement
relating to the Employment Agreement dated as of February 6, 2004 between
Quinton Cardiology Systems, Inc. ("Quinton") and you (the "Employment
Agreement"), which was assumed by Cardiac Science Corporation (the "Company")
pursuant to the Merger Agreement dated as of February 28, 2005, as amended June
23, 2005, among the Company, Quinton, Cardiac Science, Inc., Rhythm Acquisition
Corporation and Heart Acquisition Corporation, and to your continued services as
Vice Chairman of the Board of Directors of the Company (the "Board"). In
accordance with Section 8 of the Employment Agreement, the Company and you
hereby agree to terminate the Employment Agreement effective as of November 9,
2005 pursuant to Section 4.2 of the Employment Agreement. In addition, effective
as of November 9, 2005 the Company agrees to pay you $75,000 per year, payable
monthly, for your continued service as Vice Chairman of the Board, until your
death, resignation or removal or the appointment of your duly qualified
successor. This compensation is in lieu of the annual retainer fee and meeting
attendance fees paid to non-employee directors. In addition, you will be
entitled to participate in equity compensation plans and programs for directors
adopted by the Board and/or Compensation Committee of the Board, subject to the
terms and conditions of such participation, including eligibility requirements,
established by the Board and/or Compensation Committee of the Board.

<PAGE>

November 9, 2005
Page 2

We appreciate and value all of the contributions you have made to the Company
over the years and are looking forward to continuing to work with you as we face
new challenges and opportunities as Cardiac Science Corporation.

                                            Very truly yours,

                                            CARDIAC SCIENCE CORPORATION

                                            /s/ Michael K. Matysik
                                            --------------------------------
                                            By: Michael K. Matysik
                                            --------------------------------
                                            Its: Senior Vice President and
                                                 Chief Financial Officer

Acknowledged and Agreed to
this 9th day of November, 2005

/s/ Ruediger Naumann-Etienne
----------------------------
Ruediger Naumann-Etienne
Notice: This opinion is subject to formal revision before publication in the Atlantic and

Maryland Reporters. Users are requested to notify the Clerk of the Court of any formal errors

so that corrections may be made before the bound volumes go to press.

DISTRICT OF COLUMBIA COURT OF APPEALS

No. 15-BG-7

IN RE: THOMAS PLIMPTON,

Respondent.

Bar Registration No. 436571 BDN: 288-14

BEFORE: Beckwith, Associate Judge, and King and Reid, Senior Judges. 

ORDER

(FILED - April 30, 2015)

On consideration of the certified order of the Court of Appeals of Maryland

disbarring respondent from the practice of law in that jurisdiction, see Attorney

Grievance Com’n of Maryland v. Plimpton, 105 A.3d 479 (Md. 2014), this court’s

January 29, 2015, order directing respondent to show cause why the reciprocal

discipline of disbarment should not be imposed, and the statement of Bar Counsel

regarding reciprocal discipline, and it appearing that respondent has failed to file

either a response to this court’s order to show cause or the affidavit as required by

D.C. Bar R. XI, §14 (g), it is

ORDERED that Thomas Plimpton is hereby disbarred from the practice of law

in the District of Columbia. See In re Sibley, 990 A.2d 483 (D.C. 2010), and In re

Fuller, 930 A.2d 194, 198 (D.C. 2007) (rebuttable presumption ofidenticalreciprocal

discipline applies to all cases in which the respondent does not participate). It is

FURTHER ORDERED that for purposes of reinstatement respondent’s period

of disbarment will not begin to run until such time as he files an affidavit that fully

complies with the requirements of D.C. Bar R. XI, § 14 (g). 

PER CURIAM
EXHIBIT 13

CERTIFICATION OF
PERIODIC FINANCIAL REPORTS UNDER 18 U.S.C 1350

In connection with the Annual Report
on Form 20-F of Syneron Medical Ltd. for the year ended December 31, 2004, as filed with
the Securities and Exchange Commission on the date hereof (the Report), the
undersigned hereby certify that:

A)
          The Report containing the financial statements fully complies with the
          requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;
          and

B)
          Information contained in the Report fairly presents, in all material respects,
          the financial condition and results of operations of the issuer.

| |  | /s/ Moshe Mizrahy
Moshe MizrahyChief Executive Officer
| |  | --------------------------------------------------------------------

| |  | /s/ David Schlachet
David SchlachetChief Financial Officer
| |  | ------------------------------------------------------------------------

Date: June 30, 2005



---

---
<PAGE>   1

                                                                     EXHIBIT 5.1

                             MORRISON & FOERSTER LLP
                            San Francisco, California


                                 July 20, 1998




Verio Inc.
8005 South Chester Street, Suite 200
Englewood, Colorado 80112

Gentlemen:

       At your request, we have examined the Registration Statement on Form S-8
executed by you on July 20, 1998, and to be filed with the Securities and
Exchange Commission (the "SEC") in connection with the registration under the
Securities Act of 1933, as amended, of an aggregate of 250,000 shares of your
common stock, $.001 par value (the "Common Stock") which will be issuable under
the 1998 Non-Employee Director Stock Incentive Plan (the "Plan").

       As your counsel in connection with the Registration Statement, we have
examined the proceedings taken by you in connection with the adoption of the
Plan and the authorization of the issuance of the shares of Common Stock under
the Plan (the "Plan Shares") and such documents as we have deemed necessary to
render this opinion.

       Based upon the foregoing, it is our opinion that the Plan Shares, when
issued and outstanding pursuant to the terms of the Plans, will be validly
issued, fully paid and non-assessable shares of Common Stock.

       We consent to the use of this opinion as an exhibit to the Registration
Statement.

                                Very truly yours,

                                MORRISON & FOERSTER LLP
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER  PURSUANT TO 18 U.S.C. SECTION 1350

I, Scott M. Colosi, Chief Financial Officer of Texas Roadhouse, Inc. (the "Company"), certify, pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)   The
Annual Report on Form 10-K of the Company for the fiscal year ended December 30, 2008 (the "Report") fully complies with the requirements
of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2)   The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 27, 2009

By:

/s/ SCOTT M. COLOSI Scott M. Colosi
Chief Financial Officer


---



QuickLinks
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Resource-Related Research Project (R24).                    

*Date:*                         December 15, 2014.                    

*Time:*                         2:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         5601 Fishers Lane 3F100, Rockville, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Robert C. Unfer, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane Room 3F40A, Bethesda, MD 20892-7616, 301-496-3775,                         *unferrc@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

 Dated: November 17, 2014.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2014-27674 Filed 11-21-14; 8:45 am]

BILLING CODE 4140-01-P
Physical Measurement Laboratory

 Office of Weights and Measures

 Laboratory Metrology Program

 100 Bureau Drive, MS 2600

 Gaithersburg, MD 20899

NIST Weights and Measures Page 1 of 1 August 2019

Office of Weights and Measures Internal Audit Request Form

The Office of Weights and Measures requires all Recognized metrology laboratories to show full 

compliance to ISO/IEC 17025:2017 by November 2020. To assist with this transition, the OWM has 

developed an Internal Audit Form job aide which uses verbatim text from ISO/IEC 17025:2017. This form 

must be completed and submitted this Recognition Submission year to fulfill the requirements of the NIST 

HB-143 Recognition Program, as stated in the 2019 Annual Submission Memorandum. To receive a copy 

of the internal audit form, OWM must receive objective evidence/proof that your laboratory has 

ownership of the ISO/IEC 17025:2017 standard (e.g., a copy of receipt of purchase or copy of the standard 

title page with the lab name included on it). This is required to comply with copyright protections of the

ISO/IEC 17025:2017 standard. In addition, the applicant must sign and agree to the condition below. This 

form should be submitted with the proof of ownership evidence of the ISO/IEC 17025:2017 standard

(scanned and email is sufficient) to Micheal Hicks (micheal.hicks@nist.gov). Once this form along with

proof of ownership evidence is received and approved, the applicant will receive a copy of the OWM 

Internal Audit Form via email. 

Confidentiality Agreement

I, _____________________________________________ (print name and laboratory), understand that 

the OWM internal audit form has verbatim text from the ISO/IEC 17025:2017 standard which is 

copyright protected. My laboratory organization possesses a purchased and lawful copy of the ISO/IEC 

17025:2017. My laboratory organization agrees not to share the internal audit form with any third party 

organizations.

__________________________________________ ___________________

Signature of Authorized Laboratory Representative Date
UNITED STATES DISTRICT COURT

FOR THE Northern District of Illinois − CM/ECF LIVE, Ver 6.3.3

Eastern Division

UNITED STATES OF AMERICA

Plaintiff,

v. Case No.: 1:20−cr−00551

Honorable Matthew F. Kennelly

Robert Czernek, et al.

Defendant.

NOTIFICATION OF DOCKET ENTRY

This docket entry was made by the Clerk on Thursday, April 29, 2021:

 MINUTE entry before the Honorable Matthew F. Kennelly as to Robert Czernek,

Debra Fazio, Mario Giannini: Telephonic status hearing held on 4/29/2021 and continued

to 5/27/2021 at 8:40 a.m. The following call in number will be used for the hearing:

888−684−8852, access code 746−1053. Defendants' appearances are waived for the

hearing. Ordered time excluded through 5/27/2021 due to the complexity of the case,

pursuant to 18 U.S.C. 3161(h)(7)(B)(iv). Mailed notice. (mma, )

ATTENTION: This notice is being sent pursuant to Rule 77(d) of the Federal Rules of

Civil Procedure or Rule 49(c) of the Federal Rules of Criminal Procedure. It was

generated by CM/ECF, the automated docketing system used to maintain the civil and

criminal dockets of this District. If a minute order or other document is enclosed, please

refer to it for additional information.

For scheduled events, motion practices, recent opinions and other information, visit our

web site at www.ilnd.uscourts.gov.

Case: 1:20-cr-00551 Document #: 35 Filed: 04/29/21 Page 1 of 1 PageID #:120
Exhibit
32.2




CERTIFICATION
FURNISHED PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the quarterly report of Patriot Scientific Corporation (the
“Company”) on Form 10-Q for the period ended November 30, 2008, as filed with
the Securities and Exchange Commission and to which this Certification is an
exhibit (the “Report”), the undersigned officer of the Company does hereby
certify, pursuant to Rule 13a–14(b) or Rule 15d–14(b) of the Securities and
Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of
the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to his knowledge:




(1)           The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:
January 9, 2009


/s/
      Clifford L. FlowersClifford
      L. Flowers
              Chief
      Financial Officer
**Exhibit        32.1**

 

 

**CERTIFICATION**

 

 

Pursuant        to 18 U.S.C. §1350, the undersigned officer of ING Life Insurance and Annuity Company        (the “Company”) hereby certifies that, to the officer’s knowledge, the        Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 (the        “Report”) fully complies with the requirements of Section 13 or 15(d), as        applicable, of the Securities Exchange Act of 1934 and that the information contained        in the Report fairly presents, in all material respects, the financial condition        and results of operations of the Company.

 

 

| November 12, 2007

            (Date) | By:    | /s/                                                         David A. Wheat |   |
|---------------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|  

                                                                                     |   | David A. Wheat

Executive Vice President and

Chief Financial Officer

                                                                                                                                      |   |

 

 

----
```

Exhibit 99.1

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cryocon, Inc. (the "Company") on Form
10-QSB for the period ending December 31, 2002 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, J. Brian Morrison,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350,
as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge and belief:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

/s/ J. Brian Morrison

J. Brian Morrison
Chief Executive Officer

Date May 20, 2003
```
<Page>

                                                                   EXHIBIT 32.02

                           SECTION 135O CERTIFICATIONS

In connection with this quarterly report of ML Futures Investments L.P. on Form
10-Q for the period ended September 30, 2004 as filed with the Securities and
Exchange Commission on the date hereof, I, Patrick Hayward certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant of the Sarbanes-Oxley Act of 2002,
that:

1. This quarterly report containing the financial statements fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and

2. The information contained in this quarterly report fairly presents, in all
material respects, the financial condition and results of operations of ML
Futures Investments L.P.

Date: November 15, 2004
-----------------------

By /s/ PATRICK HAYWARD
   -------------------
Patrick Hayward
Chief Financial Officer
(Principal Financial and Accounting Officer)

                                       19
#### Sally Jones, etc., *v.*Littleton Jones, etc.

Descent and Distribution — Child of Void Marriage.

Under 1 M. & B. Stat. 565, and R. S., ch. 47, § 2, subd. 3, legitimatizing the issue of void marriages, tbe daughter of a void marriage is capable of inheriting from her father.

APPEAL FROM BOURBON CIRCUIT COURT.

January 6, 1873.

Opinion by

Judge Peters :

It is satisfactorily established by the evidence that appellees, Lit-tleton Jones and his sister Julia, are the children of the intestate Edward Jones, born in lawful wedlock. But the further facts are established by the evidence that said Edward Jones abandoned his wife, Katy, the mother of said appellees, about 1844, and removed from Nashville, Tennessee, to Kentucky, and perhaps in 1850 married appellant, Sally Jones, cohabited with her and- recognized her as his wife when her daughter Christiana was born. At the time said intestate married appellant Sally, his wife Katy was living, and from whom1 he had not been lawfully divorced. His marriage with appellant Sally Jones was null and void. But the question then arises as to what is the condition of the issue of the last marriage.

The 19th section of an act approved 19th of March, 1796, 1 M. *262& B. Statute Laws of Ky. 565, provides that the issue in marriage deemed null in law shall nevertheless be legitimate, and consequently such issue would take by descent from its parents. That was the law: of the state in 1850, when the intestate Edward Jones married the appellant Sally, and the rights of appellant Chris-tiana must be measured by the law in force at the time of the marriage of her parents.

*Hargis, Huston, for appellants.*

*Davis, for appellees.*

But if tested by the Revised Statutes the rights of Christiana would not be changed. By Subdivision 3, Sec. 2, Chapter *47,*R. S., the marriage of her parents would be void, but by Sec. 3 she would be legitimate, and capable of inheriting from her father. Vol. 2, p. 4, R. S.

So that in either aspect of the case Christiana Jones was entitled by descent to an undivided one-third of the real estate of intestate. Sally Jones was not entitled to dower in the estate, nor are the facts presented in her amended answer sufficient to entitle her to any relief, but the judgment must be reversed and the cause remanded with directions to adjudge to Christiana Jones the one-third of the house and lot described in the petition, or to the one-third of the proceeds and for further proceedings consistent herewith.